Lafayette, IN, United States of America

Stephen Richard Ash

This inventor holds 62 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 1 EPO patent, primarily in Dialysis Systems (CPC class A61M). Top assignees: Renal Solutions, Inc., Ash Medical Systems, Inc., Hemocleanse, Inc.. Active years: 1978-2025.

USPTO Granted Patents = 62 

% Patents Active = 87.1

 

 

Average Co-Inventor Count = 1.5

ph-index = 39

Forward Citations = 8,309(Granted Patents)

Forward Citations (Not Self Cited) = 8,148(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • West Lafayette, IN (US) (1994 - 2001)
  • Lafayette, IN (US) (1978 - 2024)

Company Filing History:

goldMedal8 out of 16 
 
Renal Solutions, Inc.
 patents
silverMedal6 out of 6 
 
Ash Medical Systems, Inc.
 patents
bronzeMedal6 out of 6 
 
Hemocleanse, Inc.
 patents
4. 6 out of 2,773 
 
Purdue Research Foundation
 patents
5. 4 out of 4 
 
Ash Access Technology, Inc.
 patents
6. 3 out of 3 
 
Hemocleanse Technologies, LLC
 patents
7. 3 out of 448 
 
Merit Medical Systems, Inc.
 patents
8. 3 out of 6 
 
Zurex Pharma, Inc.
 patents
9. 2 out of 19 
 
Biotek, Inc.
 patents
10. 2 out of 670 
 
Fresenius Medical Care Holdings, Inc.
 patents
11. 2 out of 2 
 
Hemocleanse Technology LLC
 patents
12. 2 out of 4 
 
Viacirq, Inc.
 patents
13. 1 out of 1 
 
Aat Catheter Technologies, LLC
 patent
14. 1 out of 1 
 
Ash Medical System, Incorporated
 patent
15. 1 out of 1 
 
Hemotherm, Inc.
 patent
16. 1 out of 13 
 
Idt Corporation
 patents
17. 1 out of 5 
 
Janin Group, Inc.
 patents
18. 1 out of 218 
 
Medical Components, Inc.
 patents
19. 1 out of 1 
 
Willo Partners
 patent
20. 7 out of 834,350 
Other
 patents
where one patent can have more than one assignee

Years Active: 1978-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Dialysis
Catheter Lock Solution
Blood Treatment
Sorbent Reactor
Antimicrobial Compositions
Fluid Flow Control
Indwelling Catheter
Peritoneal Access
62 patents (USPTO):Explore Patents

Title: Innovator Stephen Richard Ash: Pioneering Advances in Catheter Technology

Introduction

Stephen Richard Ash, an esteemed inventor based in Lafayette, Indiana, holds an impressive portfolio of 59 patents primarily focused on advancements in catheter technology. His innovative work has significantly impacted medical practices, particularly in the realm of peritoneal dialysis and catheter lock solutions.

Latest Patents

Among his latest patents, the "Slotted Peritoneal Access Catheter" introduces a T-shaped design that enhances fluid flow through unique slit-shaped ports. This innovative design allows for high outflow and inflow rates while minimizing fluid velocity, thereby improving patient care in peritoneal dialysis procedures. Another noteworthy patent, the "Catheter Lock Solution Comprising Sodium Citrate and Benzyl Alcohol," explores methods to enhance catheter patency and reduce microbial infection risk. This composition, made up of about 10% sodium citrate and approximately 1.5% benzyl alcohol, is designed to maintain density similar to blood during the lock period, ensuring effective retention in indwelling catheters.

Career Highlights

Throughout his career, Stephen has collaborated with various organizations, including Renal Solutions, Inc. He has played a vital role in pioneering catheter innovations that have contributed to better outcomes in medical procedures involving intravenous and peritoneal access.

Collaborations

In his innovative journey, Stephen has worked alongside distinguished colleagues such as David John Carr and Janusz Steczko. Their collaboration has further propelled advancements in catheter technology and ensured the success of groundbreaking projects.

Conclusion

Stephen Richard Ash exemplifies the spirit of innovation in engineering and medical technology. His extensive array of patents and collaboration with other inventors highlight his commitment to enhancing patient care through practical and inventive solutions in catheter technology. With a career dedicated to solving complex medical challenges, Stephen continues to influence the future of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…